

The efficacy of the Soberana 02 vaccine candidate in its three-dose schedule together with Soberana Plus is 91.2%, which exceeds the World Health Organization (WHO) requirements for a vaccine candidate against COVID-19 to become a vaccine, which is 50%.
Read more Efficacy of Soberana 02 and Soberana Plus three-dose scheme achieves 91.2%

The number of people diagnosed with Covid-19 in Cuba today rises to more than seven thousand, after 65 new cases from 10 provinces of this Caribbean nation were reported in the last 24 hours.
Read more Cuba with more than seven thousand diagnosed cases of Covid-19
Page 382 of 500